Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
Background The dynamic change in C-reactive protein (CRP) levels, CRP kinetics, is a prognostic factor for metastatic renal cell carcinoma (mRCC) in the tyrosine kinase inhibitor era. We investigated the impact of early CRP kinetics on the efficacy of nivolumab in patients with mRCC.Methods We perfo...
Enregistré dans:
Auteurs principaux: | Toshiki Kijima, Shohei Fukuda, Kazutaka Saito, Yosuke Yasuda, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Yukio Kageyama, Yasuhisa Fujii |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMJ Publishing Group
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f825a204d6ee4a078c4f34cf42d92aee |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Correction: Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
Publié: (2021) -
Comparison of anterior chamber flare among different glaucoma surgeries
par: Tanito M, et autres
Publié: (2019) -
Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
par: Alexander N Shoushtari, et autres
Publié: (2021) -
Complete regression of metastatic malignant melanoma endoscopically after nivolumab administration
par: Dae Gon Ryu, et autres
Publié: (2021) -
Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma
par: Koji Nakajima, et autres
Publié: (2021)